Related Experiment Videos
[Cholera update and vaccination problems]
1Unité du Choléra et des Vibrions, Institut Pasteur, Paris, France. fournier@pasteur.fr
Medecine Tropicale : Revue Du Corps De Sante Colonial
|November 13, 1998
Summary
Cholera vaccines are crucial for prevention where hygiene is poor. Current oral vaccines show mixed results, prompting research into new conjugate vaccines targeting Vibrio cholerae O1 for infant protection.
Area of Science:
- Public Health
- Vaccinology
- Infectious Diseases
Background:
- Cholera remains a significant global public health challenge, particularly in regions with inadequate sanitation and hygiene infrastructure.
- Effective long-term cholera control relies on improved hygiene, safe water, and sanitation, which are often unattainable goals for many nations.
- The development of an effective cholera vaccine is therefore critical for disease prevention in vulnerable populations.
Purpose of the Study:
- To review the status of oral cholera vaccine research and development.
- To highlight the limitations and safety concerns of existing cholera vaccine candidates.
- To introduce a novel vaccine development strategy based on inducing antibodies against Vibrio cholerae O1 O-specific polysaccharide.
Main Methods:
- Evaluation of two large-scale human trials of oral cholera vaccines: one inactivated whole-cell/B-subunit vaccine and one live attenuated Vibrio cholerae O1 strain CVD 103-HgR.
- Assessment of vaccine efficacy and safety data from trials in Bangladesh and Indonesia.
- Exploration of a new vaccine development hypothesis focusing on immunoglobulin G (IgG) targeting the O-specific polysaccharide of Vibrio cholerae O1.
Main Results:
- The inactivated vaccine showed potential utility in refugee crises, while the live attenuated vaccine demonstrated unexpectedly low protection in a large Indonesian trial.
- Safety concerns for live cholera vaccines include the potential for horizontal gene transfer and reversion to virulence.
- A new approach aims to develop conjugate vaccines by eliciting protective IgG antibodies against Vibrio cholerae O1.
Conclusions:
- Existing oral cholera vaccines have limitations in efficacy and safety, necessitating further research.
- The development of cholera conjugate vaccines targeting the O-specific polysaccharide presents a promising strategy for conferring protective immunity.
- This new approach holds potential for protecting infants, a critical demographic for cholera prevention.